baber/WOPTO huggingface dataset:
Patent JP-H11505222-A (JP)
Title: ２〜６時間の活性成分放出期間をもつ上皮小体ホルモンの医薬投与形態
IPC: A61K38/22
Filed: 1996-05-09
Abstract: (57)【要約】
本発明は、２〜６時間の活性成分放出期間をもつ上皮小体ホルモン又は上皮小体ホルモン誘導体の医薬投与形態、このような医薬投与形態の調製のための上皮小体ホルモンの使用、及び人体における骨粗しょう症の使用方法に関する。
Patent JP-H11505844-A (JP)
IPC: A61K47/42
Filed: 1996-05-16
Abstract: An oral dosage composition for intestinal delivery comprising (A) a biologically active ingredient; and (B) zonula occludens toxin, as well as a method for the use of the same.
Patent JP-2000509821-A (JP)
Title: マルチセンサ型対象物予測検出システム
IPC: G01S13/931
Filed: 1998-02-17
Abstract: (57)【要約】
衝突対象物の瞬時距離、相対速度、衝突角度、および、衝突点を検出するためのマルチセンサ型対象物予測検出システムであって、各々が変調キャリア信号を送信するとともに対象物からの反射変調キャリア信号を受信するためのものであって、互いに固定距離だけ離間して配置された、複数のトランスデューサデバイスと；各反射信号から、ドップラーシフトした複数の調和成分を検出するための検出デバイスと；調和成分の強度に基づいて、各トランスデューサデバイスからの対象物の瞬時距離を決定するための、距離決定デバイスと；調和成分の周波数に基づいて対象物の瞬時相対速度を決定するための速度計測デバイスと；距離決定デバイスと速度計測デバイスとによる結果に基づいて、対象物との衝突が起こるよりも前に、対象物との衝突が起こる場合には車両に対しての対象物の衝突点および衝突角度を決定するための衝突決定デバイスと；を具備している。
Patent JP-2001513648-A (JP)
IPC: C12Q1/6879
Filed: 1998-03-04
Abstract: The invention relates to a detection method performed on a maternal serum or plasma sample from a pregnant female, which method comprises detecting the presence of a nucleic acid of foetal origin in the sample. The invention enables non-invasive prenatal diagnosis including for example sex determination, blood typing and other genotyping, and detection of pre-eclampsia in the mother.
Patent JP-2000514344-A (JP)
IPC: F01N3/01
Filed: 1997-05-20
Abstract: A method and a reactor for electrochemical conversion of a material (21) being insoluble in a fluid into a material being soluble in the fluid, which method comprises that a flow of the fluid is passed to a reaction zone which comprises an internal circuit consisting of: one or more working electrodes (12), one or more counter-electrodes (13), and one or more ion-selective electrolytes (11), and which internal circuit is applied with an electrical voltage difference sufficient for the electrochemical processes; and use thereof for removal of soot particles from flue gasses and removal of oil in waste water.
Patent JP-2000511143-A (JP)
IPC: B65G39/16
Filed: 1997-05-28
Abstract: PCT No. PCT/NO97/00135 Sec. 371 Date Dec. 28, 1998 Sec. 102(e) Date Dec. 28, 1998 PCT Filed May 28, 1997 PCT Pub. No. WO97/45345 PCT Pub. Date Dec. 4, 1997A belt steering assembly for centering of conveyor belts (5) comprises a mechanism with steering rollers (1) and guide rollers (9). In the event of a lateral misalignment of the belt (5), the belt's movement will be transferred from the guide rollers (9) to the steering rollers (1), with the result that the steering rollers return the belt to a neutral position. Preferred ratios are described between different lengths of a lever arm (6) for transfer of the movement. A method for loading of a conveyor belt comprises moving the conveyor belt (5) laterally before loading to a position where the centre of gravity of the loaded material (15) falls on the conveyor belt's central portion (12), and after loading steering the conveyor belt laterally to its neutral position.
Patent JP-2000505277-A (JP)
Title: バス強調用装置とその方法
IPC: G10L21/007
Filed: 1998-04-03
Abstract: (57)【要約】
音信号の疑似的な低周波の心理音響学的感覚（疑似エルエフピーエス）を聴取者に伝えるための装置は、該音信号から高い周波数の信号と関心のある低周波範囲上に伸びる低周波信号（エルエフ信号）とを得ることが出来る周波数ユニットを備えている。調波発生器は該周波数発生器に接続されており、そして関心のある該低周波範囲内の各基本周波数に対して調波の列を有する残留調波信号を発生することが出来る。各基本周波数に関して発生される該調波列は該基本周波数の調波の第１のセットの中からの少なくとも２つの連続する調波を含む調波の第１グループを含んでいる。該調波発生器に接続されたラウドネス発生器は該低周波信号の該ラウドネスを整合するように該残留調波信号の該ラウドネスをもたらすことが出来る。合計ユニットは心理音響学的代替え信号を得るように該残留調波信号と該高い周波数の信号とを合計することが出来る。
Patent JP-2001518927-A (JP)
Title: 強い着色のフォトクロミックな２Ｈ−ナフト［１，２−ｂ］ピランおよび複素環ピラン
IPC: C09K9/02
Filed: 1998-03-25
Abstract: (57)【要約】
一般式（Ｉ）（式中、Ｒ 1 およびＲ 2 の一方または両方は４−アミノアリール基であり；Ｒ 5 は直鎖または分岐Ｃ 1 −Ｃ 10 アルキル、Ｃ 1 −Ｃ 20 シクロアルキル、Ｃ 1 −Ｃ 20 ビシクロアルキル、Ｃ 1 −Ｃ 20 ポリシクロアルキル、直鎖または分岐Ｃ 1 −Ｃ 10 ハロアルキル、直鎖または分岐Ｃ 1 −Ｃ 10 パーハロアルキル、直鎖または分岐Ｃ 1 −Ｃ 10 パーハロアルケニル、直鎖または分岐Ｃ 1 −Ｃ 10 アルケニル、Ｃ 1 −Ｃ 10 アルキニル、直鎖または分岐Ｃ 1 −Ｃ 10 アルコキシ、直鎖または分岐Ｃ 1 −Ｃ 10 アルキルチオ、直鎖または分岐Ｃ 1 −Ｃ 10 アルコキシ（直鎖または分岐Ｃ 1 −Ｃ 10 アルキル）、直鎖または分岐Ｃ 1 −Ｃ 10 ヒドロキシアルキル、直鎖または分岐Ｃ 1 −Ｃ 10 アミノアルキル、アリール、フェニル、ヘテロアリール、ハロゲン、ニトリル、ニトロ、アミノ、直鎖または分岐Ｃ 1 −Ｃ 20 アルコキシカルボニル、ヒドロキシル、ホルミル、アセチル、アミド、Ｃ 1 −Ｃ 5 アルキルアミド、Ｃ 1 −Ｃ 5 ジアルキルアミド、アロイル、ベンゾイル、アルキルＣ 1 −Ｃ 5 アミノ、ジアルキルＣ 1 −Ｃ 5 アミノ、アリールアミノ、ジアリールアミノ、アリールＣ 1 −Ｃ 5 アルキルアミノおよび環状アミノ基、アリールスルフィニル、アリールスルファニル、アリールスルホニル、直鎖または分岐Ｃ 1 −Ｃ 10 アルキルスルホニル、Ｐ（Ｏ）（Ｏ−Ｃ 1 −Ｃ 10 アルキル） 2 から選択されるか、またはアルケニル基（II）（式中、Ｒ 11 および／またはＲ 12 および／またはＲ 13 は水素またはＲ 5 の定義と同じである）であり、Ｒ 3 、Ｒ 4 およびＲ 6 −Ｒ 10 は各々水素またはＲ 1 、Ｒ 2 またはＲ 5 の定義と同じである。）で表されるナフト［１，２−ｂ］ピラン。この化合物はポリマーホスト材料、例えばプラスチックまたはガラスと組み合わせてサングラスレンズ、眼科レンズまたは窓を作ることができる。
Patent JP-2001524098-A (JP)
Title: 重合体−白金化合物
IPC: A61K47/48
Filed: 1998-04-15
Abstract: (57)【要約】
腫瘍の処置で使用する重合体-白金化合物が記述されている。この化合物は、重合体骨格に沿って間隔を置いて配置された白金含有側鎖を有する重合体骨格から構成されている。これらの側鎖は、一端でこの骨格に結合され、そして他端でこの白金化合物に結合されたオリゴペプチドから構成されている。
Patent JP-2001524040-A (JP)
Title: 立体造形法を用いた三次元物体の構築においてパルス放射線源を用いた硬化可能な媒体の露出を制御する装置および方法
IPC: B29C67/00
Filed: 1998-04-22
Abstract: (57)【要約】
パルス放射線のビームに曝されたときに硬化可能な媒体から三次元物体を形成する方法および装置であって、ビームがこの媒体の標的表面上の所望のパルス位置に向けられたときに放射線のパルスが発生する。本発明の好ましい実施の形態は、レーザとパルス発生回路を含むパルスレーザアセンブリ、制御コンピュータ、複数のミラーおよびミラーエンコーダを含む。このコンピュータは、硬化可能な媒体の表面に亘りレーザビームを導くミラーの動きを制御する。レーザビームのパルスは、ミラーの位置に関連付けられ、したがって、時間に依存していない。ビームの位置に結びつけられたパルスにより、物体の形成のためのパルスビームを制御された状態で繰り返し使用することができる。
Patent JP-2001517243-A (JP)
IPC: A61Q1/10
Filed: 1998-05-13
Abstract: Disclosed are topical compositions which provide good coverage of skin imperfections, e.g., pores and uneven skin tone, while retaining a natural skin appearance. The compositions contain a particulate material having a refractive index of at least about 2, e.g., TiO2.
Patent JP-2002506562-A (JP)
Title: 少なくとも１つの放電ランプの点灯回路装置
IPC: H05B41/298
Filed: 1999-04-01
Abstract: (57)【要約】
本発明は、負荷回路（Ｎ１、Ｌ１、Ｃ４）が後置接続されたハーフブリッジインバータ（Ｑ１、Ｑ２）と、負荷回路（Ｎ１、Ｌ１、Ｃ４）とハーフブリッジインバータ（Ｑ１、Ｑ２）とに接続された少なくとも１つの結合コンデンサ（Ｃ３）と、異常な点灯状態が発生した際にハーフブリッジインバータ（Ｑ１、Ｑ２）を遮断する遮断装置（Ｔ１、Ａ）とを備え、負荷回路（Ｎ１、Ｌ１、Ｃ４）が少なくとも１つの放電ランプ（ＬＰ）用の端子を有している少なくとも１つの放電ランプの点灯回路装置に関する。本発明によれば、この回路装置が、少なくとも１つの結合コンデンサ（Ｃ３）の電圧降下を監視し少なくとも１つの結合コンデンサ（Ｃ３）で検出された電圧降下に応じて遮断装置（Ｔ１、Ａ）を作動するための手段（Ｖ１、Ｖ２）を有する。
Patent MX-157863-A (MX)
Inventor: NAHRA JOHN E
IPC: A23L3/18
Filed: 1980-10-09
Abstract: A method for maintaining a stable liquid level in a pressurized chamber is described. According to this method a liquid to be treated is heated by direct contact with steam with the consequential condensate being mixed with the treated liquid and removed from said chamber. The following steps are provided: establishing a desired flow rate of liquid to be treated into said chamber, supplying saturated steam to said chamber to heat said liquid by contact heating to condense the steam, collecting the treated liquid along with the condensed water from the steam to maintain a predetermined liquid level in said chamber, varying the rate of steam supply and pressure to maintain the predetermined treatment temperature of the liquid as it is removed from the chamber, and selecting and using for each liquid to be treated a fixed flow area device (276) to control the rate of removal of said treated liquid from said chamber to maintain said predetermined liquid level irrespective of variation of control and said steam supply. An advantageous application field of this method is a process for heating fluids to a relatively high temperature, such as sterilization of UHT temperature, in which the liquid is heated by direct contact with steam while it is held in the form of a very thin, free-falling or a continuous falling stream.
Patent MX-155562-A (MX)
Inventor: HERMAN THOMAS
IPC: H03K17/13
Filed: 1983-12-21
Abstract: The relay has two separate and identical power thyristors 210 and 211 connected in anti-parallel arrangement. The powerthyristors are each optically switched, lateral conduction devices and both are switched by illuminating their surface by reflected illumination from an LED 225. Each thyristor is provided with a respective control circuit which includes a MOSFET transistor 230-231, for clamping its respective thyristor gate whenever the voltage across the thyristor exceeds a given absolute value or whenever there is a high dV/dt transient across the thyristor. The control circuit for the control transistor includes a capacitance divider 236-239, one element of which is the distributed capacitance 238, 239 of the control transistor; a resistor 234, 235 and a zener diode 232, 233. The control circuit components may be integrated into the thyristor chips. Each of the two identical power chips and the LED chip are spaced from one another and mounted on an alumina substrate. <IMAGE>
Patent MX-158152-A (MX)
Inventor: IRIKURA TSUTOMU
IPC: C07D513/20
Filed: 1984-12-28
Abstract: The invention provides a novel spiro-linked pyrrolidine-2,5-dione of the formula;- <CHEM> wherein X1 and X2 each independently represent a hydrogen, a halogen atom, a lower alkyl or lower alkoxy group; Y is a methylene group, oxygen or sulfur atom; R1, R2, R3 and R4 each independently represent a hydrogen atom, a lower alkyl group or forming a benzene ring together with their adjacent carbon atoms; the base salts thereof with pharmaceutically acceptable cations, and processes for their manufactures. The compounds of formula [I] useful as aldose reductase inhibitors and as therapeutic agents for treatment of chronic diabetic complications are also disclosed.
Patent NZ-194777-A (NZ)
Title: N-aminoalkyl-n'-(2-chloroethyl)-n'-nitroso-ureas and pharmaceutical compositions
Inventor: BREGNEDAL P
IPC: C07C239/00
Filed: 1980-08-26
Abstract: N-nitrosourea derivatives having the formula: 
<CHEM>
 wherein X and Y are the same or different, and are selected from the group consisting of a phenyl group and a cyclohexyl group, said phenyl and cyclohexyl groups being optionally substituted with one or two substituents selected from a halogen atom, a lower alkyl group having from one to four carbon atoms inclusive, a trifluoro methyl group, a cyano group, a phenyl group, a cyclohexyl group and a lower alkyloxy group having from one to four carbon atoms inclusive. "Alkylene" is an alkylene group, branched or unbranched, having from one to four carbon atoms inclusive, and R<1> and R<2> are the same or different, and are each selected from the group consisting of lower alkyl groups having from one to four carbon atoms inclusive and benzyl groups, or they form together with the nitrogen atom a saturated five- or sixmembered heterocyclic ring, as well as pharmaceutically acceptable acid addition salts thereof. 
<??>These compounds are prepared by nitrosating the corresponding urea, which are disclosed. They show antineoplastic effectiveness and can be used in pharmaceutical compositions.
Patent NZ-203833-A (NZ)
Title: 4-(substituted alkyl)-n-(1,3-dithiolan-2-ylidene)aniline derivatives
Inventor: HARRISON B L
IPC: C07D339/06
Filed: 1983-04-08
Abstract: N-(1-3-dithiolan-2-ylidene)-4-alkylanilines having a hydroxy, alkoxy or alkanoyloxy substituent on the alkyl group are useful as anti-inflammatory agents, as analgesic agents and as antiasthmatic agents. The compounds involved can be prepared by the reaction of an appropriate 4-alkylaniline with a methyl(1,3-dithiolan-2-ylidene)sulfonium salt or with carbon disulfide and ethylene dibromide in the presence of a base.
Patent NZ-210850-A (NZ)
Title: Imidazodiazepine derivatives and pharmaceutical compositions
Inventor: HUNKELER W
IPC: C07D487/14
Filed: 1985-01-16
Abstract: There is presented compounds of the formula    <IMAGE>  I  wherein A together with the two carbon atoms denoted by  alpha  and  beta signifies one of the groups    <IMAGE> (1)   <IMAGE> (2)   <IMAGE> (3)  and   <IMAGE> (4)  and the dotted line signifies the double bond present in cases (1), (2) and (4) and wherein R1 signifies a 5- or 6-membered aromatic heterocyclic group or the group -C(R6)=NOR7(B), R2 signifies hydrogen and R3 signifies hydrogen or lower alkyl or R2 and R3 together signify dimethylene, trimethylene or propenylene, R4 and R5 each signify hydrogen, halogen, trifluoromethyl, cyano, nitro, amino or lower alkyl, R6 signifies hydrogen or lower alkyl and R7 signifies lower alkyl, the compound of formula I having the (S) or (R,S) configuration with reference to the carbon atom denoted by gamma  when R2 and R3  together signify dimethylene, trimethylene or propenylene, and pharmaceutically acceptable acid addition salts thereof have a pronounced affinity to the central benzodiazepine receptors and have anxiolytic, anticonvulsant, muscle relaxant and sedative-hypnotic properties.
Patent NZ-219193-A (NZ)
Title: Piperazinyl pyridines and piperinyl-imidazoles and pharmaceutical compositions; intermediates
Inventor: CROSS P E
IPC: C07D213/74
Filed: 1987-02-05
Abstract: A compound of the formula: 
<CHEM>
 or a pharmaceutically acceptable salt thereof, wherein <<Het>> is selected from (a) a 3- or 4-pyridinyl group optionally substituted by one or two substituents each independently selected from C1-C4 alkyl and amino, (b) a 2-pyridinyl group substituted by an amino group, (c) a 2-imidazolyl group optionally substituted by one or two C1-C4 alkyl groups and (d) a 2-, 3- or 4-pyridinyl group substituted by a nitro group, or an N-oxide thereof, or a 2-, 3- or 4-pyridinyl group substituted by a group of the formula -NHCOO(C1-C4 alkyl);
 R is selected from (a) -NHSO2R<3> where R<3> is C1-C4 alkyl, C3-C7 cycloalkyl or -NR<1>R<2> where R<1> and R<2> are each independently M or C1-C4 alkyl, (b) -SO2NR<1>R<2>where R<1> and R<2> are as defined above, (c) nitro, (d) amino and (e) acetamido;
 and X is a group of the formula -(CH2)m- where m is an integer of from 1 to 4, -CO(CH2)n- or -CH(OH)(CH2)n- where n is 1, 2 or 3.
Patent NZ-219375-A (NZ)
Title: Stimulating hair growth using cultured lower follicular cells
Inventor: OLIVER ROY F
IPC: A61K35/36
Filed: 1987-02-23
Abstract: The present invention relates to a method of stimulating hair growth in part of the skin of a mammal. The method comprises selecting lower follicular dermal cells and culturing them. An opening is then formed in the skin and the cultured dermal cells introduced through the opening in the outer epidermis layer of the skin into contact with the dermis, with said cultured dermal cells in association with epidermis cells.The invention also provides a hair growth stimulating combination comprising cultured lower follicular dermal cells in admixture with epidermis cells, as well as such cultured dermal cells for use in the preparation of an injection composition for stimulating hair growth in human skin.
Patent NZ-222678-A (NZ)
Title: Process for the stereospecific preparation of 2-arylpropionic acids with the aid of microorganisms
Inventor: BERTOLA M A
IPC: C12P41/00
Filed: 1987-11-25
Abstract: A stereospecific process for the preparation of a pharmaceutically active compound in at least 70% by weight S-configuration of the formula <CHEM> or a pharmaceutically acceptable salt or ester thereof, wherein R1 represents an optionally substituted aryl group such as a phenyl or naphthyl group, or R1 represents a heterocyclic ring system, which is optionally substituted, or R1 represents a heteroaromatic ring system optionally containing in addition to carbon atoms one or more atoms of nitrogen, sulphur or oxygen atoms, this ring system being optionally substituted, comprises subjecting a compound of the formula <CHEM> wherein R2 is an alkyl group containing at least 3 carbon atoms, to the action of a micro-organism or substances derived therefrom capable of stereoselective oxidation of compound (II) into compound (I), having at least 70% by weight S-configuration.
Patent NZ-225702-A (NZ)
Title: Preparation of meso dialkyl-2,5-dihaloadipate
Inventor: O'NEILL BRIAN T
IPC: C07C55/40
Filed: 1988-08-05
Abstract: The present process produces the meso dialkyl 2,5-dihaloadipate from a mixture of the racemic dialkyl 2,5-dihaloadipate and meso 2,5-dihaloadipate. In the disclosed process, a 2,5-dihaloadipoyl halide is formed under conditions which result in the formation of an acidic compound. The 2,5-dihaloadipoyl halide is then esterified under conditions wherein the ester of the dihaloadipoyl halide is allowed to remain in contact with the acidic compound, thus allowing the racemic diester to epimerize in the presence of the acidic compound to the meso form and then the meso diester spontaneously crystallizes. In the last stage, the meso diester produced is removed.
Patent NZ-228159-A (NZ)
Title: Transparent metal oxide and metal films
Inventor: GILLERY FRANK HOWARD
IPC: G02B1/10
Filed: 1989-02-28
Abstract: A method for producing visually neutral high transmittance low emissivity coated articles comprising infrared reflective metal and antireflective metal oxide layers and an improved multiple layer coated article produced thereby comprising a high refractive index neutral metal oxide layer between the antireflective metal oxide layer and the infrared reflective metal layer are disclosed.
Patent NZ-241411-A (NZ)
Title: Method and system for improving the thermal efficiency of a thermodynamic cycle by generating multi-component liquid working streams
Inventor: KALINA ALEXANDER ISAI
IPC: F01K25/10
Filed: 1992-01-27
Abstract: A high pressure gaseous working stream is expanded, producing a spent stream. The spent stream is condensed, producing a condensed stream. The rich and lean streams are generated by forming from the condensed stream a first partially evaporated stream and a second partially evaporated stream. The partially evaporated stream is separated in a first vapor stream and a first liquid stream, and the second partially evaporated stream is separated into a second vapor stream and a second liquid stream. The first vapor stream evaporates the rich stream and the second vapor stream is combined with a mixing stream to generate the lean stream. <IMAGE>
Patent NZ-242246-A (NZ)
Title: Amidinophenylalanine derivatives and pharmaceutical compositions.
Inventor: STUBER WERNER
IPC: A61K31/555
Filed: 1992-04-06
Abstract: Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and pharmaceutical compositions which contain these compounds are described.
Patent NZ-244243-A (NZ)
Title: Pharmaceutical composition comprising a mixture of a uricosuric agent and an excitatory amino acid antagonist
Inventor: BIGGE CHRISTOPHER FRANKLIN
IPC: A61P25/28
Filed: 1992-09-07
Abstract: The present invention is a pharmaceutical composition having a combination of an uricosuric agent such as probenecid or the like and an excitatory amino acid antagonist useful for treating a disease advantageously affected by treatment with an excitatory amino acid antagonist.
Patent NZ-245850-A (NZ)
Title: Acoustic noise reduction in speech sound signal by subtracting spectral noise components
Inventor: ROBBE FRANCOIS
IPC: G10L21/0208
Filed: 1993-02-05
Abstract: According to the invention, the method consists in:   cyclically converting, by Fourier transform, digital signals resulting from analog/digital conversions of signals provided by two microphones a fixed distance apart and receiving the said sound signal into two series of discrete data, each discrete datum of the said series representing the energy and the phase of a frequency channel of the spectrum of the said sound signal; determining the dominant angle of arrival of the said sound signal from the phase differences between the discrete data corresponding to the same frequency channels of the said series, the said dominant angle of arrival corresponding to the angle of arrival of the said speech signal;   obtaining an instantaneous spectrum of the said sound signal; updating a noise spectrum by comparing, for each frequency channel of the said instantaneous spectrum, of which the absolute value of the difference between the said dominant angle of arrival and the angle of arrival of the relevant frequency channel with a tolerance threshold value, the energies of the said frequency channels of the said noise spectrum being updated with the aid of the energies of the frequency channels of the said instantaneous spectrum, of which the absolute value of the difference between the said dominant angle of arrival and the angle of arrival of these frequency channels is greater than the said tolerance threshold value; subtracting the said updated noise spectrum from the said instantaneous spectrum to obtain a spectrum of the said speech signal.
Patent NZ-247961-A (NZ)
Title: Pyrazole derivatives and pharmaceutical compositions
Inventor: BARTH FRANCIS
IPC: A61K31/4402
Filed: 1993-06-23
Abstract: The subject of the invention is pyrazole derivatives of formula I:   <IMAGE>  in which   - g2, g3, g4, g5, g6 and w2, w3, w4, w5 and w6 are identical or different and independently represent hydrogen, a chlorine or bromine atom, a (C1-C3)alkyl, a (C1-C3)alkoxy, a trifluoromethyl or a nitro group and g4 optionally represents a phenyl group;   - R4 represents hydrogen or a (C1-C3)alkyl; - X represents either a direct bond or a group -(CH2)x-N(R3)- in which R3 represents hydrogen or a (C1-C3)alkyl and x represents zero or one;   - R represents   . a group -NR1R2, in which R1 and R2 independently represent a (C1-C6)alkyl group; an optionally substituted, nonaromatic (C3-C15)carbocyclic radical; an amino(C1-C4)alkyl group in which the amino is optionally disubstituted by a (C1-C3)alkyl; a cycloalkyl(C1-C3)alkyl in which the cycloalkyl is (C3-C12); a phenyl which is unsubstituted or substituted one or more times by a halogen, by a (C1-C5)alkyl or by a (C1-C5)alkoxy; a phenyl(C1-C3)alkyl; a diphenyl(C1-C3)alkyl; a naphthyl; an anthryl; a saturated, 5- to 8-membered heterocyclic radical which is unsubstituted or substituted by a (C1-C3)alkyl, hydroxyl or benzyl; a 1-adamantylmethyl; an aromatic heterocycle which is unsubstituted or substituted one or more times by a halogen, a (C1-C5)alkyl or a (C1-C5)alkoxy; a (C1-C3)alkyl which is substituted by an aromatic heterocycle which is unsubstituted or substituted one or more times by a halogen, a (C1-C5)alkyl or a (C1-C5)alkoxy; or else R1 is hydrogen and R2 is as defined above; or yet again R1 and R2 constitute, with the nitrogen atom to which they are bonded, a saturated, 5- to 8-membered heterocyclic radical, the said heterocyclic radical being other than morpholinyl when w2, w3, w4, w5, w6, g2, g3, g4, g5 and g6 are all hydrogen;   . a group R2 as defined above when X represents -(CH2)xN(R3)-; . a group R5 when X represents a direct bond, R5 being represented by a (C1-C3)alkyl; a (C3-C12)cycloalkyl which is unsubstituted or substituted by a (C1-C5)alkyl; a phenyl(C1-C3)alkyl which is unsubstituted or substituted by a halogen or by a (C1-C5)alkyl; a cycloalkyl(C1-C3)alkyl in which the cycloalkyl is C3-C12 and is unsubstituted or substituted by a (C1-C5)alkyl; or a 2-norbornylmethyl;    or one of their optional salts. Application: therapeutic treatment of pathological conditions where cannabis is involved.
Patent NZ-253083-A (NZ)
Title: Fluid bed with spraying of granular liquid downwards onto fluid bed of powdered material
Inventor: SCHLEICHNER WERNER
IPC: A23K40/10
Filed: 1993-05-27
Abstract: A process is disclosed for constructively granulating a powdery material in a fluidized bed equipment. The granulating liquid containing a binder is sprayed downwards on the fluidized bed of material to be granulated in countercurrent to the fluidized bed-generating gas by means of two-component fan jet nozzles. With charge quantities on the order of about 1000 kg, very uniform and dust-free granulates can thus be obtained.